# Role of Main Red Seaweed Bioactive Compounds in Modulating Redox Imbalance and Cholinergic Dysfunction: Insights from In Vitro Assays

**Authors:** João Ferreira, Mário Pacheco, Amélia M. Silva, Isabel Gaivão

PMC · DOI: 10.3390/cimb48020190 · 2026-02-07

## TL;DR

This review explores how compounds from red seaweed can help reduce oxidative stress and improve cholinergic function, which are important in diseases like Alzheimer's.

## Contribution

The paper systematically reviews in vitro evidence for red seaweed compounds modulating redox imbalance and cholinergic dysfunction.

## Key findings

- Red seaweed compounds showed antioxidant activity through radical scavenging and metal chelation.
- They inhibited acetylcholinesterase and modulated inflammatory mediators like nitric oxide and cytokines.
- The findings suggest these compounds could be useful as functional food ingredients.

## Abstract

Oxidative and nitrosative stress are key contributors to the development and progression of chronic inflammatory disorders, cancer and neurodegenerative diseases (viz., Alzheimer’s disease). Cholinergic dysfunction is a major hallmark of Alzheimer’s disease and is closely associated with these processes. Red seaweeds are rich in bioactive compounds that have been increasingly investigated for their potential to modulate these processes. This review aims to examine the role of major red seaweed-derived metabolites in regulating redox imbalance, immunomodulatory capacity and acetylcholinesterase activity, with emphasis on in vitro studies. An analysis of peer-reviewed literature was conducted, focusing on chemical, biochemical and cell-based assays. Studies assessed antioxidant activity, anti-inflammatory and immunostimulatory effects, and acetylcholinesterase inhibition of isolated compounds/fractions of red seaweed using established methods, including radical scavenging assays, Griess-based nitrite assay and enzyme inhibition assays. Sulfated polysaccharides, oligosaccharides, mycosporine-like amino acids (MAAs), phycoerythrin, bromophenols, phlorotannin and terpenoid-derived metabolites demonstrated antioxidant capacity through radical scavenging, metal chelation and modulation of endogenous antioxidants. They also modulated inflammatory mediators, including nitric oxide and pro-inflammatory cytokines, and inhibited acetylcholinesterase (AChE) activity. In vitro evidence supports red seaweed-derived compounds as promising modulators of redox homeostasis, inflammation and cholinergic function, highlighting their relevance as functional food ingredients, while underscoring the need for in vivo and clinical validation.

## Linked entities

- **Chemicals:** nitric oxide (PubChem CID 145068)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, Alox5 (arachidonate 5-lipoxygenase) [NCBI Gene 11689] {aka 5-LO, 5-LOX, 5LO, 5LX, F730011J02}, CAT [NCBI Gene 2847485], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}
- **Diseases:** cardiovascular disorders (MESH:D002318), hyperoxaluria (MESH:D006959), nutrient deficiencies (MESH:D007153), necrosis (MESH:D009336), chronic (MESH:D002908), cognitive decline (MESH:D003072), depression (MESH:D003866), bacterial infections (MESH:D001424), neuronal loss (MESH:D009410), cancer (MESH:D009369), diabetes mellitus (MESH:D003920), brain atrophy (MESH:C566985), AD (MESH:D000544), atrophy (MESH:D001284), neuroinflammation (MESH:D000090862), Inflammation (MESH:D007249), Neurodegenerative disorders (MESH:D019636), injury to (MESH:D014947), Mitochondrial dysfunction (MESH:D028361), neurofibrillary tangles (MESH:D055956), Cholinergic (MESH:C535672)
- **Chemicals:** AA (MESH:D000596), nitrite (MESH:D009573), RNS (MESH:D026361), monoterpenes (MESH:D039821), L-arginine (MESH:D001120), MDA (MESH:D008315), amine (MESH:D000588), Cl (MESH:D002713), amino alcohols (MESH:D000605), donepezil (MESH:D000077265), rivastigmine (MESH:D000068836), H2O2 (MESH:D006861), 6,6'-bieckol (MESH:C062360), Fe (-), superoxide (MESH:D013481), imine (MESH:D007097), shinorine (MESH:C494891), oligosaccharides (MESH:D009844), cellulose (MESH:D002482), H+ (MESH:D006859), Rn (MESH:D011886), xanthophylls (MESH:D024341), acetate (MESH:D000085), ROS (MESH:D017382), porphyran (MESH:C038549), heavy metals (MESH:D019216), peroxynitrite (MESH:D030421), 3,6-anhydrogalactose (MESH:C117625), GSH (MESH:D005978), asterina-330 (MESH:C570559), ATP (MESH:D000255), alpha-tocopherol (MESH:D024502), agarose (MESH:D012685), OH (MESH:C031356), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (MESH:C002502), lipid (MESH:D008055), LPS (MESH:D008070), Choline (MESH:D002794), methane (MESH:D008697), prostaglandins (MESH:D011453), polysaccharide (MESH:D011134), polymers (MESH:D011108), porphyra-334 (MESH:C421025), ketones (MESH:D007659), chlorophyll (MESH:D002734), Agar (MESH:D000362), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), Trolox (MESH:C010643), (-)-elatol (MESH:C485576), metal (MESH:D008670), phytol (MESH:D010836), Br (MESH:D001966), carrageenan (MESH:D002351), Oxygen (MESH:D010100), sulfate (MESH:D013431), Zn (MESH:D015032), acid (MESH:D000143), 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (MESH:C439224), alkaloid (MESH:D000470), L-citrulline (MESH:D002956)
- **Species:** Homo sapiens (human, species) [taxon 9606], Gelidium pristoides (species) [taxon 58179], Symphyocladia latiuscula (species) [taxon 396806], Pyropia haitanensis (species) [taxon 1262161], Pyropia yezoensis (susabi-nori, species) [taxon 2788], Porphyra sp. (species) [taxon 2790], Mus musculus (house mouse, species) [taxon 10090], Gelidiella acerosa (species) [taxon 28867], Gracilaria gracilis (species) [taxon 2777], Gracilaria caudata (species) [taxon 2572395], Escherichia coli (E. coli, species) [taxon 562], Porphyra umbilicalis (laver, species) [taxon 2786], Asparagopsis armata (species) [taxon 31367], Ochtodes secundiramea (species) [taxon 508042]
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), IEC-6 — Rattus norvegicus (Rat), Finite cell line (CVCL_0343), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), THP-1-Blue — Homo sapiens (Human), Burkitt lymphoma, Cancer cell line (CVCL_1967), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939525/full.md

---
Source: https://tomesphere.com/paper/PMC12939525